Evidence-Based Clinical Practice Guideline For Attention Deficit Hyperactivity Disorder (ADHD) .

This clinical practice guideline is for the identification, diagnosis, and treatment of people with ADHD.

It outlines a roadmap for ADHD clinical practice, research and policy, now and in the future, with a focus on everyday functioning and quality of life for people who are living with ADHD and those who support them.

The Guideline includes eight chapters covering the identification, diagnosis, and treatment of people with ADHD, as well as considerations for subgroups, service & policy and further research.

1. Identification
2. Diagnosis
3. Treatment & Support
4. Non-Pharmacological Interventions
5. Pharmacological Interventions
6. Considerations – Subgroups
7. Considerations – Service & Policy
8. Considerations – Research

Approvals

This guideline has been approved by the NHMRC and endorsed by APS, RACP, RACGP, Speech Pathology Australia, Occupational Therapy Australia, ACPA, AAPI, ADHD WA, ADHD Foundation, RANZCP, ADHD Australia and the World Federation of ADHD.

The guidelines can be downloaded at the link below:

https://aadpa.com.au/guideline/